Digest Network Come funziona
Network
/
Società
Pe
Non verificato

PepGen Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

41 comunicati stampa

Guarda tutti i comunicati
06/08/2026
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
06/08/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
21/05/2026
Biotecnologia
Salute
Eventi
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
12/05/2026
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
30/03/2026
Web e Social Network
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
04/03/2026
Mercato azionario
Eventi
Salute
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
04/03/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
PepGen Announces Regulatory Updates on FREEDOM2
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
03/03/2026
Eventi
Web e Social Network
Biotecnologia
Salute
PepGen to Participate in the Leerink Global Healthcare Conference
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
09/12/2025
Mercato del lavoro
Salute
Biotecnologia
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0
08/12/2025
Mercato del lavoro
Industria
Salute
Sanità
Farmaceutica
Biotecnologia
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
Fonte
PepGen Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0